Biotin and glucose dual-targeting, ligand-modified liposomes promote breast tumor-specific drug delivery
Graphical abstract
Section snippets
Declaration of Competing Interest
The authors declare that they have no known competing financial interests or personal relationships that could have appeared to influence the work reported in this paper.
Acknowledgments
This work was supported by the National Natural Science Foundation of China (No. 81573286, No. 81773577, No. 21472130, and No. 81803420), the Sichuan Science and Technology Program (2018JY0537).
References (26)
- et al.
Awareness and current knowledge of breast cancer
Biol Res
(2017) Breast Cancer Epidemiol
(2010)- et al.
Prodrugs for improving tumor targetability and efficiency
Adv Drug Deliv Rev
(2011) - et al.
A review on the efficacy and toxicity of different doxorubicin nanoparticles for targeted therapy in metastatic breast cancer
Biomed Pharmacother
(2017) - et al.
Synthesis of a novel, sequentially active-targeted drug delivery nanoplatform for breast cancer therapy
Biomaterials
(2015) - et al.
Glutathione PEGylated liposomes: pharmacokinetics and delivery of cargo across the blood-brain barrier in rats
J Drug Target
(2014) - et al.
Biotin-conjugated tumour-targeting photocytotoxic iron(III) complexes
Philos Trans R Soc A Math Phys Eng Sci
(2013) - et al.
Regulation of cancer cell metabolism
Nat Rev Cancer
(2011) - et al.
Cancer cell metabolism: Warburg and beyond
Cell
(2008) - et al.
Cellular uptake of glucoheptoamidated poly(amidoamine) PAMAM G3 dendrimer with amide-conjugated biotin, a potential carrier of anticancer drugs
Bioorganic Med Chem
(2017)
Recent development of biotin conjugation in biological imaging, sensing, and target delivery
Chem Commun
Growth inhibition of human ovarian carcinoma by a novel AvidinOX-anchored biotinylated camptothecin derivative
Bioorg Med Chem Lett
An update on therapeutic opportunities offered by cancer glycolytic metabolism
Bioorg Med Chem Lett
Cited by (22)
Functionalized liposomes for targeted breast cancer drug delivery
2023, Bioactive MaterialsUtility of various drug delivery systems and their advantages and disadvantages
2023, Nanotechnology for Drug Delivery and PharmaceuticalsChallenges and emerging strategies for next generation liposomal based drug delivery: An account of the breast cancer conundrum
2023, Chemistry and Physics of LipidsA new chitosan-based thermosensitive nanoplatform for combined photothermal and chemotherapy
2022, International Journal of Biological MacromoleculesCitation Excerpt :Biotin is one suitable ligand. It is an essential micronutrient for cell proliferation [40,41], and its receptor, sodium-dependent multivitamin transporter, is overexpressed on the surfaces of numerous cancer cell membranes, including those of breast cancer cells and human cervical cancer cells [42–45]. Moreover, biotin is a small molecule with advantages of low cytotoxicity and no inherent immunogenicity [46].
Effect of surface ligand modification on the properties of anti-tumor nanocarrier
2022, Colloids and Surfaces B: BiointerfacesCitation Excerpt :Chemotherapy is one of the common methods of cancer treatment. Although these drugs have good therapeutic effects, many chemotherapeutic agents are highly toxic and non-targeted with serious adverse effects[2–5]. Therefore, in order to improve the limitations of chemotherapeutic drugs, many researchers have developed nanocarriers for the delivery of anti-cancer drugs.
Fabrication of active targeting lipid nanoparticles: Challenges and perspectives
2022, Materials Today Advances